1.13
price up icon3.67%   0.04
after-market After Hours: 1.18 0.05 +4.42%
loading
Neuronetics Inc stock is traded at $1.13, with a volume of 284.26K. It is up +3.67% in the last 24 hours and up +32.96% over the past month. Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$1.09
Open:
$1.1
24h Volume:
284.26K
Relative Volume:
0.69
Market Cap:
$34.24M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-1.00
EPS:
-1.13
Net Cash Flow:
$-39.26M
1W Performance:
+11.88%
1M Performance:
+32.96%
6M Performance:
-70.34%
1Y Performance:
-19.29%
1-Day Range:
Value
$1.05
$1.16
1-Week Range:
Value
$0.9807
$1.16
52-Week Range:
Value
$0.664
$5.0699

Neuronetics Inc Stock (STIM) Company Profile

Name
Name
Neuronetics Inc
Name
Phone
877-600-7555
Name
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Name
Employee
203
Name
Twitter
@tmstherapy
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
STIM's Discussions on Twitter

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-13-21 Downgrade BTIG Research Buy → Neutral
Oct-13-21 Downgrade William Blair Outperform → Mkt Perform
Jan-22-21 Upgrade William Blair Mkt Perform → Outperform
Feb-06-20 Initiated BTIG Research Buy
Jul-24-18 Initiated Canaccord Genuity Buy

Neuronetics Inc Stock (STIM) Latest News

pulisher
05:44 AM

A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb - Simply Wall St

05:44 AM
pulisher
01:51 AM

Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World

01:51 AM
pulisher
Nov 02, 2024

Neuronetics to Unveil Q3 2024 Financial Results - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Neuronetics extends Madryn registration rights period By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Neuronetics extends Madryn registration rights period - Investing.com India

Nov 01, 2024
pulisher
Oct 29, 2024

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call - The Manila Times

Oct 29, 2024
pulisher
Oct 24, 2024

Transcranial Magnetic Stimulator Market Projected To Witness Substantial Growth, 2024-2031:Nexstim Plc, - EIN News

Oct 24, 2024
pulisher
Oct 17, 2024

Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com

Oct 17, 2024
pulisher
Oct 14, 2024

NeuroStar TMS data presented at AACAP meeting By Investing.com - Investing.com Australia

Oct 14, 2024
pulisher
Oct 14, 2024

NeuroStar TMS data presented at AACAP meeting - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - The Manila Times

Oct 14, 2024
pulisher
Oct 14, 2024

Transcranial Magnetic Stimulator Market will generate new - openPR

Oct 14, 2024
pulisher
Oct 11, 2024

Neuronetics executive sells shares worth over $1,200 By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 11, 2024

Neuronetics executive sells shares worth over $1,200 - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

Neuronetics EVP Stephen Furlong sells shares worth over $1,100 - Investing.com India

Oct 11, 2024
pulisher
Oct 04, 2024

Neuronetics faces potential Nasdaq delisting - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics faces potential Nasdaq delisting By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics Moves to Acquire Greenbrook in Stock Deal - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics Set to Acquire Greenbrook TMS - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings - StockTitan

Oct 04, 2024
pulisher
Oct 02, 2024

Neuronetics Outlines Greenbrook Acquisition Prospects and Risks - TipRanks

Oct 02, 2024
pulisher
Oct 02, 2024

SEC Form DEFA14A filed by Neuronetics Inc. - Quantisnow

Oct 02, 2024
pulisher
Oct 02, 2024

Neuronetics Expands TMS Access for Adolescents with Depression - MyChesCo

Oct 02, 2024
pulisher
Oct 02, 2024

Neuronetics GAAP EPS of -$0.27 beats by $0.04, revenue of $17.42M beats by $0.3M - MSN

Oct 02, 2024
pulisher
Sep 30, 2024

STIM stock rated a Mkt perform by William Blair - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

In the Green: Neuronetics Inc (STIM) Closes at 0.75, Up/Down -3.85 from Previous Day - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 27, 2024

Neuronetics Inc (STIM) deserves closer scrutiny - US Post News

Sep 27, 2024
pulisher
Sep 26, 2024

Neuronetics Inc [STIM] Shares Fall -6.18 % on Wednesday - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Neuronetics Inc (STIM) Stock: A Year of Declines and Increases - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

Quarterly Snapshot: Quick and Current Ratios for Neuronetics Inc (STIM) - The Dwinnex

Sep 26, 2024
pulisher
Sep 25, 2024

Stoke Therapeutics Inc (STOK) expanding its growth trajectory ahead - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Neuronetics announces HCSC expanded access to TMS for adolescents - TipRanks

Sep 25, 2024
pulisher
Sep 25, 2024

In the Green: NeuroSense Therapeutics Ltd (NRSN) Closes at 1.25, Up/Down -3.50 from Previous Day - The Dwinnex

Sep 25, 2024
pulisher
Sep 25, 2024

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents - Yahoo Finance

Sep 25, 2024
pulisher
Sep 25, 2024

NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule - PR Newswire

Sep 24, 2024
pulisher
Sep 24, 2024

How did Stoke Therapeutics Inc (STOK) fare last session? - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Logos Global Management LP Invests $14.19 Million in Stoke Therapeutics, Inc. (NASDAQ:STOK) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Recent Insider Activity Could Benefit Stoke Therapeutics Inc (STOK) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 4.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

STIM Stock Likely to Gain From Updated TMS Coverage - Zacks Investment Research

Sep 23, 2024
pulisher
Sep 22, 2024

First Eagle Investment Management LLC Purchases 260,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo

Sep 21, 2024
pulisher
Sep 19, 2024

Neuronetics Enhances NeuroStar Therapy with New Features - MSN

Sep 19, 2024
pulisher
Sep 19, 2024

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults - StockTitan

Sep 19, 2024
pulisher
Sep 18, 2024

Acadian Asset Management LLC Purchases 62,628 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Greenbrook TMS announces acquisition by Neuronetics - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

STIM’s Stock Swings: Riding the 2023 Wave of Ups and Downs - The InvestChronicle

Sep 17, 2024

Neuronetics Inc Stock (STIM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Neuronetics Inc Stock (STIM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
Oct 08 '24
Sale
0.82
1,541
1,264
402,792
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
Cap:     |  Volume (24h):